文献速递脑血管病外科神经重症

入院时外周单核细胞增多预测蛛网膜下腔出血患者的脑梗死及不良功能结局

Peripheral Monocytosis at Admission to Predict Cerebral Infarct and Poor Functional Outcomes in Subarachnoid Hemorrhage Patients.
PubMed 文献 · World Neurosurg · 2020-03-06

本研究纳入204例蛛网膜下腔出血患者,发现入院时外周单核细胞升高与脑梗死独立相关(OR 3.193,95%CI 1.069-9.532,P=0.037)。单核细胞计数0.60为预测脑梗死的最佳截断值(AUC=0.622,P=0.010)。单核细胞≥0.60与出院时及12个月不良功能结局相关。

要点

  • 入院单核细胞升高是蛛网膜下腔出血后脑梗死的危险因素(OR 3.193)。
  • 单核细胞0.60为预测脑梗死最佳截断值,AUC=0.622。
  • 单核细胞≥0.60与出院时和12个月不良功能结局相关。

核心结论

  • 入院时外周单核细胞增多是蛛网膜下腔出血后发生脑梗死的危险因素。
  • 短期和长期不良临床结局与较高的单核细胞计数相关。
  • 单核细胞可能作为预后不良的便捷生物标志物及新治疗策略的潜在靶点。

研究设计与样本

  • 纳入204例诊断为蛛网膜下腔出血的患者。
  • 收集患者相关因素、合并症、Hunt-Hess分级、改良Fisher分级、治疗、迟发性脑缺血、脑梗死、动脉瘤特征及入院时静脉血外周单核细胞。
  • 不良结局定义为改良Rankin量表评分≥3。

主要发现

  • 50例(24.5%)患者在出院前发生脑梗死。
  • 多因素模型校正IV-V级Hunt-Hess分级和迟发性脑缺血后,入院时单核细胞升高与脑梗死显著相关(OR 3.193,95%CI 1.069-9.532,P=0.037)。
  • 受试者工作特征曲线分析中,单核细胞计数0.60为区分脑梗死发生的最佳截断值(AUC=0.622,P=0.010)。
  • 单核细胞<0.60组脑梗死发生率为17.4%,单核细胞≥0.60组为29.1%(P=0.046)。
  • 入院单核细胞≥0.60预测出院时不良功能结局(单核细胞<0.60组52% vs 单核细胞≥0.60组64.7%)及12个月不良功能结局(单核细胞<0.60组29.4% vs 单核细胞≥0.60组70.6%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Increasing evidence points monocytes' role to be larger than thought in developing cerebral infarction (CI) after subarachnoid hemorrhage (SAH). However, there is no clinical evidence of the relationship between peripheral monocytes and CI and clinical outcomes. Therefore we determine whether an increase in monocytes in the acute phase is useful to predict CI and functional outcomes in SAH patients. METHODS: We included 204 patients with an SAH diagnosis. We collected patient-related factors, comorbidities, Hunt-Hess grade, modified Fisher grade, treatment, delayed cerebral ischemia, CI, aneurysm characteristics, and peripheral monocytes from vein blood at admission. Poor outcomes were defined as modified Rankin Scale score ≥3. RESULTS: Fifty (24.5%) patients had CI before discharge. In a multivariate model, increased monocytes at admission were significantly associated with CI after adjusting for IV-V Hunt-Hess grade and delayed cerebral ischemia (odds ratio: 3.193, 95% confidence interval: 1.069-9.532, P = 0.037). In receiver operating characteristic curve analysis, a monocyte count of 0.60 was identified as the best cutoff value to discriminate the development of CI (area under the curve = 0.622, P = 0.010; CI for monocytes <0.60 17.4% vs. CI for monocytes ≥0.60 29.1% P = 0.046). Admission monocytes ≥0.60 predicted poor functional outcomes at discharge (monocytes <0.60 52% vs. monocytes ≥0.60 64.7%) and at 12 months (monocytes <0.60 29.4% vs. monocytes ≥0.60 70.6%). CONCLUSIONS: Increased peripheral monocytes at admission is a risk factor for developing CI after SAH. Moreover, short- and long-term poor clinical outcomes were associated with higher monocyte count. Therefore monocytes could be a convenient biomarker for prognosis unfavorable outcomes and a possible target for new therapeutic strategies.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Unda SR, Birnbaum J, Labagnara K, et al. Peripheral Monocytosis at Admission to Predict Cerebral Infarct and Poor Functional Outcomes in Subarachnoid Hemorrhage Patients. World Neurosurg. 2020. PMID: 32151773. doi:10.1016/j.wneu.2020.02.170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。